Baseline variables | HIV-1 positive | HIV negative | Community control (Sgr V) | P value | |||||
(at enrolment) | Fe pos (Sgr I) | Fe neg (SgrII) | Fe pos (SgrIII) | Fe neg (SgrIV) | Overall | I vs II | III vs IV | ||
n = 60 | n = 58 | n = 30 | n = 50 | n= 40 |
|
|
| ||
Consumption of iron tablets/day | Range No | 6 - 14 9.97 ± 1.8** | NA* NA* | 4 - 14 9.70 ± 2.6 | NA* NA* | NA* NA* |
|
|
|
Hemoglobin (gm/dl)*** |
| 12.9 ± 0.39 | 12.6 ± 0.26 | 12.7 ± 0.32 | 12.5 ± 0.22 | 12.8 ± 0.21 | <0.001 | <0.001 | 0.03 |
Serum iron (µmol/l)*** |
| 40.1 ± 5.49 | 17 ± 3.33 | 41.2 ± 4.6 | 16.2 ± 3.3 | 16.6 ± 3.21 | <0.001 | <0.001 | <0.001 |
Serum Ferritin (µg/l)*** |
| 349 ± 106 | 86 ± 16 | 371 ± 80 | 77 ± 21 | 90 ± 24 | <0.001 | <0.001 | <0.001 |
Transferrin saturation (%) |
| 65.3 ± 9.5 | 30.3 ± 4.4 | 70.1 ± 5.7 | 32.5 ± 5.9 | 31.4 ± 4.6 | <0.001 | <0.001 | <0.001 |